MIR548AS

Across TCGA pan-cancer cohorts, MIR548AS RNA is linked to patient survival in 7 of 34 cancer types, making it the most broadly survival-associated MIR548AS data layer.

The strongest signal is observed in pancreatic adenocarcinoma (PAAD), where higher MIR548AS RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR548AS expression acts as an unfavorable survival marker.

PAAD, SKCM, and BLCA are the cancer types where MIR548AS RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
PAAD	OS	Tertile	All	0.182	0.497	.006	54	view →
SKCM	DFS	Tertile	All	0.209	0.728	.020	36	view →
BLCA	DFS	Tertile	All	0.096	0.626	<.001	36	view →
STAD	OS	Tertile	III,IV	0.316	0.643	.010	36	view →
LUSC	DFS	Tertile	All	0.027	0.749	<.001	27	view →
GBM	DFS	Tertile	All	0.071	0.288	.009	18	view →
LGG	OS	Tertile	All	0.504	0.891	.008	3	view →

Pink = unfavorable, green = favorable. Showing the 7 strongest of 7 lineages.

MIR548AS–PAAD (OS)

Open the PAAD breakdown →